Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G7SM
|
|||
| Former ID |
DIB015821
|
|||
| Drug Name |
AEA-35p
|
|||
| Synonyms |
Peptide vaccines (H1N1 influenza virus infection), Antigen Express
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 1 | [1] | |
| Company |
Antigen Express Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | MHC class II antigen DR (HLA-DR) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035645) | |||
| REF 2 | WO patent application no. 2013,1850,32, Nanotherapeutics for drug targeting. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.